で公開中です! 詳しく見る
ATCのアイコン

GraniteShares Autocallable COIN ETF

23.96 USD
終値時点 更新済み 10月16日 16:00 EDT
1日
5日間
1か月
3か月
6か月
年初来
1年
5年間
10年間

ニュース

ポジティブ
ニュートラル
ネガティブ
センチメント 3か月間
ポジティブ 0%
ニュートラル 0%
ネガティブ 0%
ニュートラル
GlobeNewsWire
3 か月前
GraniteShares Announces Monthly Distributions for its Autocallable ETFs: ANV, TLA, MSR, ATC, PLA, AHD, SCA and MRA
New York, July 02, 2026 (GLOBE NEWSWIRE) -- GraniteShares today announced the monthly distributions for its GraniteShares Autocallable ETFs: ANV, TLA, MSR, ATC, PLA, AHD, SCA and MRA as shown in the table below.
GraniteShares Announces Monthly Distributions for its Autocallable ETFs: ANV, TLA, MSR, ATC, PLA, AHD, SCA and MRA
ニュートラル
Business Wire
4 か月前
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced its participation at the American Transplant Congress (ATC) 2026, taking place June 20–24 in Boston, Massachusetts. Real-world clinical use and scientific advancements involving AlloSure® Kidne.
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress
ニュートラル
GlobeNewsWire
4 か月前
Memo Therapeutics AG Presents Complete Phase II Clinical Trial Data for Potravitug in Kidney Transplant Recipients at the American Transplant Congress 2026
Schlieren / Zurich, Switzerland, 18 June, 2026 – Memo Therapeutics AG (“MTx”), a late-stage biotech company translating unique immune responses into superior medicines to treat viral infections and cancer, announces the presentation of data from its Phase II clinical trial of potravitug at the American Transplant Congress (ATC) 2026, taking place from 20-24 June in Boston, USA.
Memo Therapeutics AG Presents Complete Phase II Clinical Trial Data for Potravitug in Kidney Transplant Recipients at the American Transplant Congress 2026
ニュートラル
Business Wire
4 か月前
Natera to Showcase Organ Health Leadership with 21 Presentations at the American Transplant Congress
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced its robust scientific presence at the upcoming American Transplant Congress (ATC), taking place June 20-24, 2026. The company and its collaborators will share 21 presentations, including seven oral presentations, highlighting the utility of the Prospera test to inform risk assessment and long-term graft monitoring across kidney, heart, lung, and multi-organ transp.
Natera to Showcase Organ Health Leadership with 21 Presentations at the American Transplant Congress
ニュートラル
Business Wire
4 か月前
World Wide Technology Launches ‘Defending at the Speed of AI' Initiative with Horizon3.ai, Empirical Security, Infoblox, and Cognition
ST. LOUIS--(BUSINESS WIRE)--World Wide Technology (WWT), a global technology solutions provider, today announced the launch of “Defending at the Speed of AI,” a global cybersecurity initiative WWT developed in collaboration with Horizon3.ai, Empirical Security, Infoblox, and Cognition. The integrated program, available in WWT's Advanced Technology Center (ATC) and Cyber Range, operates at machine speed to address a critical gap in modern security infrastructure: the accelerating pace of AI-powe.
World Wide Technology Launches ‘Defending at the Speed of AI' Initiative with Horizon3.ai, Empirical Security, Infoblox, and Cognition
価格チャートは Lightweight Charts™ を使用して実装されています